A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Amedisys Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 4,400 shares of AMED stock, worth $425,920. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,400
Previous 3,300 33.33%
Holding current value
$425,920
Previous $304,000 32.57%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$90.4 - $96.77 $11 Million - $11.8 Million
121,581 New
121,581 $11.2 Million
Q4 2023

Feb 14, 2024

SELL
$91.15 - $95.89 $5.9 Million - $6.21 Million
-64,757 Reduced 93.26%
4,679 $444,000
Q3 2023

Nov 14, 2023

BUY
$89.84 - $94.08 $4.78 Million - $5.01 Million
53,223 Added 328.27%
69,436 $6.49 Million
Q2 2023

Aug 14, 2023

SELL
$73.99 - $92.6 $36.1 Million - $45.2 Million
-488,021 Reduced 96.78%
16,213 $1.48 Million
Q1 2023

May 15, 2023

BUY
$69.79 - $100.33 $16.6 Million - $23.9 Million
237,826 Added 89.27%
504,234 $37.1 Million
Q4 2022

Feb 14, 2023

BUY
$80.12 - $105.34 $6.4 Million - $8.42 Million
79,915 Added 42.85%
266,408 $22.3 Million
Q3 2022

Nov 14, 2022

BUY
$96.79 - $131.14 $3.89 Million - $5.27 Million
40,210 Added 27.49%
186,493 $18.1 Million
Q2 2022

Aug 15, 2022

BUY
$105.12 - $173.85 $15 Million - $24.8 Million
142,512 Added 3779.16%
146,283 $15.4 Million
Q1 2022

May 16, 2022

SELL
$124.79 - $178.09 $1.52 Million - $2.18 Million
-12,219 Reduced 76.42%
3,771 $650,000
Q4 2021

Feb 14, 2022

SELL
$136.32 - $184.41 $23.8 Million - $32.2 Million
-174,598 Reduced 91.61%
15,990 $2.59 Million
Q3 2021

Nov 15, 2021

BUY
$149.1 - $270.32 $18.5 Million - $33.5 Million
123,798 Added 185.35%
190,588 $28.4 Million
Q2 2021

Aug 16, 2021

SELL
$238.97 - $288.5 $465,752 - $562,286
-1,949 Reduced 2.84%
66,790 $16.4 Million
Q1 2021

May 17, 2021

SELL
$236.62 - $314.16 $12.1 Million - $16.1 Million
-51,157 Reduced 42.67%
68,739 $18.2 Million
Q4 2020

Feb 16, 2021

SELL
$231.3 - $293.33 $16.7 Million - $21.2 Million
-72,171 Reduced 37.58%
119,896 $35.2 Million
Q3 2020

Nov 16, 2020

BUY
$199.22 - $248.1 $744,086 - $926,653
3,735 Added 1.98%
192,067 $45.4 Million
Q2 2020

Aug 14, 2020

BUY
$169.77 - $213.81 $24.7 Million - $31.1 Million
145,381 Added 338.48%
188,332 $37.4 Million
Q1 2020

May 15, 2020

BUY
$137.21 - $202.02 $1.34 Million - $1.97 Million
9,748 Added 29.36%
42,951 $7.88 Million
Q4 2019

Feb 14, 2020

SELL
$122.85 - $167.13 $811,424 - $1.1 Million
-6,605 Reduced 16.59%
33,203 $5.54 Million
Q3 2019

Nov 14, 2019

SELL
$117.97 - $137.89 $4.17 Million - $4.88 Million
-35,357 Reduced 47.04%
39,808 $5.22 Million
Q2 2019

Aug 14, 2019

SELL
$108.08 - $129.67 $30.3 Million - $36.3 Million
-280,263 Reduced 78.85%
75,165 $9.13 Million
Q1 2019

May 15, 2019

BUY
$110.76 - $138.73 $16.5 Million - $20.6 Million
148,613 Added 71.86%
355,428 $0
Q4 2018

Feb 14, 2019

BUY
$98.2 - $140.23 $12.4 Million - $17.7 Million
125,965 Added 155.8%
206,815 $24.2 Million
Q3 2018

Nov 13, 2018

BUY
$87.74 - $125.01 $3.45 Million - $4.91 Million
39,292 Added 94.55%
80,850 $0
Q2 2018

Aug 10, 2018

SELL
$60.06 - $87.93 $216,095 - $316,372
-3,598 Reduced 7.97%
41,558 $0
Q1 2018

May 11, 2018

SELL
$50.51 - $62.74 $5.56 Million - $6.91 Million
-110,127 Reduced 70.92%
45,156 $2.72 Million
Q4 2017

Feb 09, 2018

BUY
$46.45 - $58.49 $3.21 Million - $4.05 Million
69,206 Added 80.4%
155,283 $8.19 Million
Q3 2017

Nov 09, 2017

BUY
$47.05 - $55.96 $4.05 Million - $4.82 Million
86,077
86,077 $4.82 Million

Others Institutions Holding AMED

About AMEDISYS INC


  • Ticker AMED
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 32,492,000
  • Market Cap $3.15B
  • Description
  • Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal...
More about AMED
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.